Page last updated: 2024-08-26

fotemustine and Hepatocellular Carcinoma

fotemustine has been researched along with Hepatocellular Carcinoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bruckner, E; Kővári, B; Langner, C; Lauwers, GY; Varelas, AI1

Other Studies

1 other study(ies) available for fotemustine and Hepatocellular Carcinoma

ArticleYear
Metachronous double-hit by transarterial chemoembolisation (TACE) with fotemustine inducing dysplasia-like atypia in the gallbladder and stomach-A diagnostic pitfall.
    Histopathology, 2022, Volume: 81, Issue:1

    Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Gallbladder; Humans; Liver Neoplasms; Nitrosourea Compounds; Organophosphorus Compounds; Stomach; Treatment Outcome

2022